Large study of Novo, Lilly weight loss drugs shows decrease in risk of Alzheimer's

According to the study, which was published Monday in Nature Medicine, researchers found that use of the new medicines may reduce the risk of Alzheimer’s disease and substance abuse disorders while increasing the risk of digestive issues and arthritis.